The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells
about
Phospholipase C delta-4 overexpression upregulates ErbB1/2 expression, Erk signaling pathway, and proliferation in MCF-7 cellsNeuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinaseA natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxisErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner.Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 ProteinNuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer.c-Src-dependent transcriptional activation of TFII-ILapatinib: a novel dual tyrosine kinase inhibitor with activity in solid tumorsCell death or survival promoted by alternative isoforms of ErbB4The ErbB signaling network: receptor heterodimerization in development and cancerErbB expression, activation, and inhibition with lapatinib and tyrphostin (AG825) in human vestibular schwannomas.Topological analysis of MAPK cascade for kinetic ErbB signaling.ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network.Complexity of signal transduction mediated by ErbB2: clues to the potential of receptor-targeted cancer therapy.Bivalence of EGF-like ligands drives the ErbB signaling networkDifferential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers.Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancerThe C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing.ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines.The HER4 cytoplasmic domain, but not its C terminus, inhibits mammary cell proliferation.Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimersSingle molecule fluorescence detection and tracking in mammalian cells: the state-of-the-art and future perspectives.Modeling the effects of HER/ErbB1-3 coexpression on receptor dimerization and biological responseBlockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility.A phase I and pharmacokinetic study of oral lapatinib administered once or twice daily in patients with solid malignancies.The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors.Role of HER2/HER3 co-receptor in breast carcinogenesis.The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patientsSystem properties of ErbB receptor signaling for the understanding of cancer progression.Stimulation of beta1-integrin function by epidermal growth factor and heregulin-beta has distinct requirements for erbB2 but a similar dependence on phosphoinositide 3-OH kinaseHuman epidermal growth factor receptor dimerization analysis in breast cancer diagnosis: potential for improving testing accuracy and treatment selection.Human epidermal growth factor receptor 4 (HER4) is a favorable prognostic marker of breast cancer: a systematic review and meta-analysis.Targeting erbB receptors.Cardiotoxicity associated with targeting kinase pathways in cancer.Cross-talk and modulation of signaling between somatostatin and growth factor receptors.Pharmacotherapy targeting the EGFR oncogene in NSCLC.Alternative intracellular routing of ErbB receptors may determine signaling potency.Experience with erlotinib in the treatment of non-small cell lung cancer.Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection.
P2860
Q21245746-0DD0FFF2-1569-43AF-9B04-DAF9459F2B08Q22009917-71128A6F-77E8-4953-8040-AE169169AAE5Q22253346-2BC6E641-6ADB-4686-91FC-0D9A9D3A106FQ24522643-47C0306B-B3E0-44CA-BDF6-5715682F6693Q27667382-0BE1BD86-E2A8-4EC2-981E-817071C31A60Q27853060-A07BF135-C4FB-4EF9-A8D7-0F85BA99A866Q28213012-41916B8C-61E7-4A08-A38B-FEAC6ACD4421Q28292264-B2324C52-C7F0-460E-8095-3C0907149E4AQ28593348-0D98A848-B1E2-439E-9C5E-59BDE5B171C6Q29617919-8B253655-BC57-401E-AF5C-54291A63BE45Q30457869-91A5B701-A75B-4436-85CA-BA83666EA077Q33323383-C1118E40-4DEE-4570-B21D-D29ACEE09A09Q33781099-FE7B8679-8E2C-43E6-A69A-5510DB9D9EA1Q33801908-30957E5D-8A7B-44A1-B3A0-420821611A70Q33887274-A788D6EA-466C-4E2B-8893-4CEA82D7FF0DQ33888963-88ED6C46-9AB4-465D-862B-573A201D7086Q33890758-DA56EBED-6564-4752-8DFF-D5D143AB775BQ33891080-DE10EE69-52A9-4D07-B730-273E23AF5ACEQ33928631-D99EBD48-076A-4683-AB2B-0F93B95A993EQ34048265-C2B140BD-1F5A-46B8-9736-18F4E0E79771Q34274718-F40B2510-7D6C-4155-8219-6EB6363F2309Q34497895-46BF2705-EA78-4A7A-9CDE-D15ED0CF0836Q34600838-FC56A213-A64F-4A0E-8753-49AE8A4FF74EQ35210178-89E72D4C-D9D8-406C-AA2F-EFA17AEA849CQ35228445-EAFF1CA6-132D-42A8-9940-358F12633586Q35597532-C5F0C66A-0723-43AA-8370-A753CB264D4EQ36334739-8F28E9CC-C065-4524-AED8-FC8C6885629DQ36429652-ADF9AF2B-0B88-4F2E-9F36-4C7EB7BB9916Q36614287-6A4A955E-AB1C-4D5D-AA38-321CEDC1D9AEQ36716462-1DB25A8B-927F-4AA1-BF3D-1FFE58C1D749Q36907061-83432AF1-B46F-46A8-8E7A-D4CF85A911F8Q37635099-C83670EB-8453-4A00-9F95-3C8737A5EC57Q37718269-8D89FCB3-1E3E-4291-B9CD-095A8F18B96BQ37789955-4E1708EF-F402-4189-A9BE-24D3F703487BQ37823035-B84347C6-AD80-4FB1-9551-6DB4BD181C8EQ37922648-D3BA89D3-D7A2-4F9C-93AE-1E06BF86D535Q38248997-CC1271AE-CED9-4025-967B-061F318C1090Q38337018-32DD17C5-43DD-44A7-9C42-AD15EA0A8FE7Q38524526-A09932FA-D920-448E-AC05-69888754D752Q38839402-A72A66B3-8474-4B39-9299-51A35077BDCA
P2860
The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells
description
1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 1996
@ast
im November 1996 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1996/11/29)
@sk
vědecký článek publikovaný v roce 1996
@cs
wetenschappelijk artikel (gepubliceerd op 1996/11/29)
@nl
наукова стаття, опублікована в листопаді 1996
@uk
name
The relationship between human ...... transformation in NIH3T3 cells
@ast
The relationship between human ...... transformation in NIH3T3 cells
@en
The relationship between human ...... transformation in NIH3T3 cells
@nl
type
label
The relationship between human ...... transformation in NIH3T3 cells
@ast
The relationship between human ...... transformation in NIH3T3 cells
@en
The relationship between human ...... transformation in NIH3T3 cells
@nl
prefLabel
The relationship between human ...... transformation in NIH3T3 cells
@ast
The relationship between human ...... transformation in NIH3T3 cells
@en
The relationship between human ...... transformation in NIH3T3 cells
@nl
P2093
P2860
P356
P1476
The relationship between human ...... transformation in NIH3T3 cells
@en
P2093
P2860
P304
30897–30903
P356
10.1074/JBC.271.48.30897
P407
P577
1996-11-29T00:00:00Z